These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38152858)

  • 1. Impact of deep transcranial magnetic stimulation on insomnia outcomes in patients with treatment-resistant depression: a retrospective study.
    Chopra A; Singal P; Kodya S
    J Clin Sleep Med; 2024 May; 20(5):813-815. PubMed ID: 38152858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with response after deep transcranial magnetic stimulation in a real-world clinical setting: Results from the first 40 cases of treatment-resistant depression.
    Feffer K; Lapidus KAB; Braw Y; Bloch Y; Kron S; Netzer R; Nitzan U
    Eur Psychiatry; 2017 Jul; 44():61-67. PubMed ID: 28545010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
    Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
    World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of deep transcranial magnetic stimulation for treatment-resistant depression: A systematic review and meta-analysis.
    Hung YY; Yang LH; Stubbs B; Li DJ; Tseng PT; Yeh TC; Chen TY; Liang CS; Chu CS
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109850. PubMed ID: 31863873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep transcranial magnetic stimulation for adolescents with treatment-resistant depression: A preliminary dose-finding study exploring safety and clinical effectiveness.
    Thai M; Nair AU; Klimes-Dougan B; Albott CS; Silamongkol T; Corkrum M; Hill D; Roemer JW; Lewis CP; Croarkin PE; Lim KO; Widge AS; Nahas Z; Eberly LE; Cullen KR
    J Affect Disord; 2024 Jun; 354():589-600. PubMed ID: 38484878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate day dTMS combined with SSRIs for chronic treatment resistant depression: A prospective multicenter study.
    Tendler A; Gersner R; Roth Y; Zangen A
    J Affect Disord; 2018 Nov; 240():130-136. PubMed ID: 30071416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality dimensions and deep repetitive transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a pilot trial on five-factor prediction of antidepressant response.
    McGirr A; Van den Eynde F; Chachamovich E; Fleck MP; Berlim MT
    Neurosci Lett; 2014 Mar; 563():144-8. PubMed ID: 24486892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neural correlates of clinical improvement after deep transcranial magnetic stimulation (DTMS) for treatment-resistant depression: a case report using functional magnetic resonance imaging.
    Harvey PO; Van den Eynde F; Zangen A; Berlim MT
    Neurocase; 2015 Feb; 21(1):16-22. PubMed ID: 24313336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durability of deep transcranial magnetic stimulation for veterans with treatment resistant depression with comorbid suicide risk and PTSD symptoms.
    Hickson R; Simonsen MW; Miller KJ; Madore MR
    Psychiatry Res; 2024 Feb; 332():115690. PubMed ID: 38183924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Deep Transcranial Magnetic Stimulation in Office Workers with Treatment-Resistant Depression: A Randomized, Double-Blind, Sham-Controlled Trial.
    Matsuda Y; Kito S; Igarashi Y; Shigeta M
    Neuropsychobiology; 2020; 79(3):208-213. PubMed ID: 31955155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep transcranial magnetic stimulation (DTMS) in the treatment of major depression: An exploratory systematic review and meta-analysis.
    Kedzior KK; Gellersen HM; Brachetti AK; Berlim MT
    J Affect Disord; 2015 Nov; 187():73-83. PubMed ID: 26321258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Add-on deep transcranial magnetic stimulation (dTMS) in patients with dysthymic disorder comorbid with alcohol use disorder: a comparison with standard treatment.
    Girardi P; Rapinesi C; Chiarotti F; Kotzalidis GD; Piacentino D; Serata D; Del Casale A; Scatena P; Mascioli F; Raccah RN; Brugnoli R; Digiacomantonio V; Ferri VR; Ferracuti S; Zangen A; Angeletti G
    World J Biol Psychiatry; 2015 Jan; 16(1):66-73. PubMed ID: 25140585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 61% of unmedicated treatment resistant depression patients who did not respond to acute TMS treatment responded after four weeks of twice weekly deep TMS in the Brainsway pivotal trial.
    Yip AG; George MS; Tendler A; Roth Y; Zangen A; Carpenter LL
    Brain Stimul; 2017; 10(4):847-849. PubMed ID: 28330592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex in depressive episodes of patients with major depressive disorder, bipolar disorder I, and major depressive with alcohol use disorders.
    Rapinesi C; Kotzalidis GD; Ferracuti S; Girardi N; Zangen A; Sani G; Raccah RN; Girardi P; Pompili M; Del Casale A;
    Neurosci Lett; 2018 Apr; 671():128-132. PubMed ID: 29454034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant effectiveness of deep Transcranial Magnetic Stimulation (dTMS) in patients with Major Depressive Disorder (MDD) with or without Alcohol Use Disorders (AUDs): a 6-month, open label, follow-up study.
    Rapinesi C; Curto M; Kotzalidis GD; Del Casale A; Serata D; Ferri VR; Di Pietro S; Scatena P; Bersani FS; Raccah RN; Digiacomantonio V; Ferracuti S; Bersani G; Zangen A; Angeletti G; Girardi P
    J Affect Disord; 2015 Mar; 174():57-63. PubMed ID: 25484178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant outcomes of high-frequency repetitive transcranial magnetic stimulation (rTMS) with F8-coil and deep transcranial magnetic stimulation (DTMS) with H1-coil in major depression: a systematic review and meta-analysis.
    Gellersen HM; Kedzior KK
    BMC Psychiatry; 2019 May; 19(1):139. PubMed ID: 31064328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot investigation of accelerated deep transcranial magnetic stimulation protocols in treatment-resistant depression.
    Filipčić I; Šimunović Filipčić I; Sučić S; Milovac Ž; Gereš N; Matić K; Čelić-Ružić M; Zečević Penić S; Orgulan I; Požgaj V; Bajić Ž
    Eur Arch Psychiatry Clin Neurosci; 2021 Feb; 271(1):49-59. PubMed ID: 32449010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep transcranial magnetic stimulation for treatment-resistant bipolar depression: a case report of acute and maintenance efficacy.
    Bersani FS; Girardi N; Sanna L; Mazzarini L; Santucci C; Kotzalidis GD; Sani G; De Rossi P; Raccah RN; Caltagirone SS; Battipaglia M; Capezzuto S; Bersani G; Girardi P
    Neurocase; 2013; 19(5):451-7. PubMed ID: 22827578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep Transcranial Magnetic Stimulation: A Promising Drug-Free Treatment Modality in the Treatment of Chronic Low Back Pain.
    Yates E; Balu G
    Del Med J; 2016 Mar; 88(3):90-2. PubMed ID: 27215046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.